StockNews.AI
THTX
StockNews.AI
186 days

Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update

1. Theratechnologies will report Q4 and full year 2024 results on February 26. 2. CEO Paul Lévesque will host the earnings call with management team members. 3. Participants should join early for optimal access to the call.

Earnings
+7.36%Current Return
VS
0%S&P 500
$1.6302/14 07:35 AM EDTEvent Start
$1.7502/17 07:57 AM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

Earnings reports can move stock prices but expectations are uncertain.

How important is it?

Upcoming financial results are significant for investor interest and company valuation.

Why Short Term?

Q4 results will impact short-term investor sentiment and trading activity.

Related Companies

THTXTH
MONTREAL, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care, today announced the Company will report financial results and provide a business update for its fourth quarter and full year fiscal 2024 ended November 30 on Wednesday, February 26, 2025, at 8:30 a.m. ET. The call will be hosted by Paul Lévesque, President and Chief Executive Officer, who will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer. They will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below. CONFERENCE CALL INFORMATIONConference Call DateFebruary 26, 2025Conference Call Time8:30 a.m. ETWebcast linkhttps://edge.media-server.com/mmc/p/2h9ningtDial in1-888-513-4119 (toll free) or 1-412-902-6615 (international)Access Code4430181CONFERENCE CALL REPLAYToll Free1-877-344-7529 (US) / 1-855-669-9658 (Canada)International Toll1-412-317-0088Replay Access Code3856571Replay End DateMarch 5, 2025To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X.  Contacts: Investor inquiries:Joanne ChoiSenior Director, Investor Relationsjchoi@theratech.com1-551-261-0401Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com1-514-336-7800

Related News